Childhood Cancer Incidence, New York City, 2011-2015

Source: New York State Cancer Registry

Site of Cancer Ages 0-4 Ages 5-9 Ages 10-14 Ages 15-19 Combined Ages 0-14 Combined Ages 0-19
Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 95% CI Avg Annual Cases Rate per 1,000,000 95% CI
All Invasive Malignant Tumors 136.4 247.0 66.0 136.4 82.8 177.5 128.2 263.0 285.2 185.6 176.0-195.5 413.4 205.1 196.3-214.1
I Leukemias 45.4 82.2 22.6 46.7 17.0 36.5 21.0 43.1 85.0 54.8 49.7-60.3 106.0 51.8 47.5-56.5
   I(a) Lymphoid leukemias 32.4 58.7 19.4 40.1 9.8 21.0 10.2 20.9 61.6 39.8 35.5-44.5 71.8 35.1 31.5-38.9
   I(b) Acute myeloid leukemia 7.2 13.0 1.6 3.3 4.2 9.0 5.6 11.5 13.0 8.4 6.4-10.7 18.6 9.2 7.4-11.2
II Lymphomas and reticuloendothelial neoplasms 10.6 19.2 10.2 21.1 18.4 39.5 30.4 62.4 39.2 26.7 23.0-30.7 69.6 35.6 32.0-39.6
   II(a) Hodgkin lymphoma 0.2 0.4 1.8 3.7 7.6 16.3 18.0 36.9 9.6 6.9 5.1-9.2 27.6 14.5 12.2-17.1
   II(b,c,d) Non-Hodgkin lymphomas 10.4 18.8 8.2 16.9 10.6 22.7 11.6 23.8 29.2 19.5 16.4-22.9 40.8 20.6 17.8-23.6
III CNS & misc intracranial & intraspinal neoplasms 23.4 42.4 18.2 37.6 14.6 31.3 12.8 26.3 56.2 37.1 32.8-41.7 69.0 34.3 30.8-38.2
   III(a) Ependymomas and choroid plexus tumor 2.4 4.3 1.4 2.9 1.2 2.6 1.0 2.1 5.0 3.3 2.1-4.8 6.0 3.0 2.0-4.2
   III(b) Astrocytoma 12.6 22.8 8.4 17.4 8.8 18.9 7.8 16.0 29.8 19.7 16.6-23.1 37.6 18.8 16.2-21.6
   III(c) Intracranial and intraspinal embryonal tum 5.2 9.4 3.8 7.9 1.6 3.4 0.8 1.6 10.6 6.8 5.1-9.0 11.4 5.5 4.2-7.2
   III(d) Other gliomas 2.6 4.7 4.2 8.7 2.2 4.7 2.8 5.7 9.0 6.1 4.4-8.1 11.8 6.0 4.5-7.7
IV Neuroblastoma and other peripheral nervous cell tumors 16.6 30.1 1.2 2.5 0.6 1.3 0.6 1.2 18.4 10.8 8.7-13.3 19.0 8.4 6.8-10.3
   IV(a) Neuroblastoma and ganglioneuroblastoma 16.4 29.7 1.0 2.1 0.4 0.9 0.2 0.4 17.8 10.4 8.4-12.8 18.0 7.9 6.3-9.7
V Retinoblastoma 9.6 17.4 0.4 0.8 0.0 0.0 0.0 0.0 10.0 5.7 4.2-7.5 10.0 4.3 3.2-5.6
VI Renal tumors 11.6 21.0 1.6 3.3 0.8 1.7 0.2 0.4 14.0 8.5 6.6-10.7 14.2 6.4 5.0-8.1
   VI(a) Nephroblastoma and other nonepithelial rena 11.6 21.0 1.6 3.3 0.4 0.9 0.0 0.0 13.6 8.2 6.3-10.4 13.6 6.1 4.7-7.8
VII Hepatic tumors 4.0 7.2 0.8 1.7 0.6 1.3 1.2 2.5 5.4 3.3 2.1-4.8 6.6 3.1 2.1-4.3
   VII(a) Hepatoblastoma 3.8 6.9 0.6 1.2 0.2 0.4 0.0 0.0 4.6 2.7 1.7-4.1 4.6 2.0 1.3-3.1
VIII Malignant bone tumors 0.6 1.1 3.4 7.0 7.2 15.4 8.6 17.6 11.2 8.0 6.0-10.3 19.8 10.4 8.5-12.7
   VIII(a) Osteosarcoma 0.0 0.0 2.2 4.5 4.8 10.3 4.4 9.0 7.0 5.0 3.5-7.0 11.4 6.0 4.6-7.8
   VIII(c) Ewing tumor and related sarcomas of bone 0.4 0.7 1.2 2.5 1.2 2.6 2.2 4.5 2.8 2.0 1.1-3.3 5.0 2.6 1.7-3.8
IX Soft tissue and other extraosseous sarcomas 8.2 14.8 4.4 9.1 8.4 18.0 9.4 19.3 21.0 13.9 11.4-16.9 30.4 15.3 12.9-17.9
   IX(a) Rhabdomyosarcoma 5.2 9.4 1.6 3.3 1.8 3.9 1.6 3.3 8.6 5.5 3.9-7.4 10.2 4.9 3.7-6.5
X Germ cell & trophoblastic tumors & gonadal neoplasms 4.4 8.0 1.4 2.9 6.6 14.2 15.6 32.0 12.4 8.2 6.3-10.6 28.0 14.2 11.9-16.8
   X(a) Intracranial and intraspinal germ cell tumo 0.4 0.7 0.4 0.8 2.6 5.6 1.2 2.5 3.4 2.4 1.4-3.8 4.6 2.4 1.5-3.6
   X(c) Malignant gonadal germ cell tumor 0.8 1.4 0.8 1.7 3.8 8.1 12.0 24.6 5.4 3.8 2.5-5.5 17.4 9.0 7.2-11.1
XI Other malignant epithelial neoplasms and malignant melanomas 1.0 1.8 1.8 3.7 8.4 18.0 28.2 57.9 11.2 8.0 6.0-10.3 39.4 20.5 17.7-23.6
   XI(b) Thyroid carcinoma 0.4 0.7 0.2 0.4 4.0 8.6 16.6 34.1 4.6 3.3 2.1-4.9 21.2 11.0 9.0-13.3
   XI(d) Malignant melanoma 0.2 0.4 0.4 0.8 0.6 1.3 3.0 6.2 1.2 0.8 0.3-1.8 4.2 2.2 1.3-3.3
XII Other and unspecified malignant neoplasms 0.8 1.4 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.5 0.1-1.2 1.0 0.4 0.1-1.1

Notes

  • Incidence data are provisional, November 2017.
  • Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases per year are unstable and should be used with caution.
  • Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).